Form 4 for ALLO Allogene Therapeutics, Inc.
Accepted 2022-07-06 00:00:00 ET · period of report 2022-07-05 · accession 0001662119-22-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-07-06 | 2022-07-05 | ALLO | Amado Rafael | CMO, EVP of R, D | S - Sale | $11.44 | -2,000 | 542.3K | -0.4% | -$22.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-05 | S | D | 2,000 | $11.44 | 542,257 | D | — | — |